# Chia

> Chia is a US telehealth platform for physician-supervised peptide, GLP-1, and hormone
> treatments across multiple health goals — weight loss, longevity, strength, recovery,
> sleep, sexual wellness and cognition. US-licensed clinicians prescribe and manage
> treatment; compounds are prepared by FDA-regulated sources and delivered to your door.

All treatments require an online health assessment and evaluation by a licensed US clinician.

## Compound reference (56 monographs, updated daily)

Every entry carries mechanism, an evidence grade computed from PubMed, the
studies behind that grade, reported dosing ranges, a dated US legal status
traced to a primary FDA source, safety and interactions. It includes compounds
Chia does not sell. Machine-readable: POST to /api/graphql with the query
query { compounds { slug name evidenceGrade legalStatus legalStatusAsOf } }

- [Compound reference index](https://chia.health/peptides)
- [Legal-status tracker — every FDA action, dated and sourced](https://chia.health/peptides/legal-status)

- [Tirzepatide](https://chia.health/blog/tirzepatide): Dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and obesity. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [Estradiol](https://chia.health/blog/estradiol): Primary human oestrogen, approved in oral, transdermal and vaginal forms. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [Progesterone](https://chia.health/blog/progesterone): Approved progestogen used in menopausal hormone therapy. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [PT-141](https://chia.health/blog/pt-141): Melanocortin-receptor agonist approved for hypoactive sexual desire disorder in premenopausal women. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [NAD+](https://chia.health/blog/nad): Essential redox cofactor central to mitochondrial metabolism and sirtuin signalling. Evidence grade A. US status: Not verified.
- [GHK-Cu](https://chia.health/blog/ghk-cu): Copper-binding tripeptide used topically for skin remodelling. Evidence grade B. US status: Not verified.
- [Glutathione](https://chia.health/blog/glutathione): Endogenous tripeptide antioxidant used in compounded injectable and inhaled forms. Evidence grade A. US status: Not verified.
- [BPC-157](https://chia.health/blog/bpc-157): Synthetic pentadecapeptide from a gastric protein, studied preclinically for tissue repair. Evidence grade C. US status: PCAC recommended — FDA has not acted (as of 2026-07-23).
- [Retatrutide](https://chia.health/blog/retatrutide): Investigational triple GIP/GLP-1/glucagon receptor agonist; not approved and not compoundable. Evidence grade A. US status: Not compoundable (as of 2026-09-02).
- [TB-500](https://chia.health/blog/tb-500): Synthetic fragment related to thymosin beta-4, studied preclinically for tissue repair. Evidence grade B. US status: PCAC recommended — FDA has not acted (as of 2026-07-23).
- [Testosterone](https://chia.health/blog/testosterone): Schedule III androgen approved for male hypogonadism. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [Epitalon](https://chia.health/blog/epitalon): Synthetic tetrapeptide studied in Russian gerontology literature for telomerase activity. Evidence grade A. US status: PCAC recommended — FDA has not acted (as of 2026-07-24).
- [KPV](https://chia.health/blog/kpv): Tripeptide C-terminal fragment of alpha-MSH studied for anti-inflammatory effects. Evidence grade A. US status: PCAC recommended — FDA has not acted (as of 2026-07-23).
- [Liraglutide](https://chia.health/blog/liraglutide): Daily GLP-1 receptor agonist approved for diabetes and weight management. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [Metformin](https://chia.health/blog/metformin): First-line biguanide for type 2 diabetes, studied in the TAME geroscience trial. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [MOTS-c](https://chia.health/blog/mots-c): Mitochondrial-derived peptide studied in metabolic regulation and exercise physiology. Evidence grade A. US status: PCAC recommended — FDA has not acted (as of 2026-07-23).
- [Rapamycin](https://chia.health/blog/rapamycin): mTOR inhibitor approved as an immunosuppressant, studied off-label in geroscience. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [Semax](https://chia.health/blog/semax): Synthetic ACTH fragment analogue used in Russia for cognitive and neurological indications. Evidence grade B. US status: PCAC recommended — FDA has not acted (as of 2026-07-24).
- [Anastrozole](https://chia.health/blog/anastrozole): Aromatase inhibitor approved in breast cancer, used off-label in hormone protocols. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [DSIP](https://chia.health/blog/dsip): Nonapeptide first isolated from rabbit cerebral venous blood, studied for sleep. Evidence grade A. US status: PCAC voted against (as of 2026-07-24).
- [Dulaglutide](https://chia.health/blog/dulaglutide): Weekly GLP-1 receptor agonist approved for type 2 diabetes. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [Methylene Blue](https://chia.health/blog/methylene-blue): Approved for methaemoglobinaemia; studied at low dose in mitochondrial and cognitive research. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [NMN](https://chia.health/blog/nmn): NAD+ precursor; FDA has excluded it from the dietary-supplement definition. Evidence grade A. US status: Not verified.
- [Oxytocin](https://chia.health/blog/oxytocin): Approved nonapeptide hormone; compounded intranasal forms are used off-label. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [CJC-1295](https://chia.health/blog/cjc-1295): Synthetic GHRH analogue, with and without drug-affinity complex. Evidence grade B. US status: Not verified.
- [Enclomiphene](https://chia.health/blog/enclomiphene): Selective oestrogen-receptor modulator studied for secondary hypogonadism; not FDA-approved. Evidence grade A. US status: Not verified.
- [Exenatide](https://chia.health/blog/exenatide): First-in-class GLP-1 receptor agonist derived from exendin-4. Evidence grade A. US status: FDA-approved product exists (as of 2026-09-02).
- [Ipamorelin](https://chia.health/blog/ipamorelin): Selective ghrelin-receptor agonist and growth-hormone secretagogue. Evidence grade A. US status: Not verified.
- [Low-Dose Naltrexone](https://chia.health/blog/ldn): Opioid antagonist approved at 50 mg, compounded at 1–5 mg for off-label immune indications. Evidence grade A. US status: Not verified.
- [MK-677](https://chia.health/blog/mk-677): Orally active non-peptide ghrelin-receptor agonist; investigational, not approved. Evidence grade A. US status: Not verified.
- [Nicotinamide Riboside](https://chia.health/blog/nicotinamide-riboside): NAD+ precursor marketed as a dietary ingredient with human pharmacokinetic data. Evidence grade A. US status: Not verified.
- [Thymosin Alpha-1](https://chia.health/blog/thymosin-alpha-1): Thymic peptide used outside the US as an immune modulator in hepatitis and sepsis. Evidence grade A. US status: Not verified.
- [AOD-9604](https://chia.health/blog/aod-9604): Growth-hormone fragment studied for lipolysis; failed its obesity endpoint in human trials. Evidence grade C. US status: Not verified.
- [Cagrilintide](https://chia.health/blog/cagrilintide): Investigational long-acting amylin analogue studied with semaglutide. Evidence grade A. US status: Not verified.
- [DHEA](https://chia.health/blog/dhea): Adrenal precursor steroid, sold as a supplement and as an approved vaginal insert. Evidence grade A. US status: Not verified.
- [GHRP-2](https://chia.health/blog/ghrp-2): Growth-hormone-releasing peptide and ghrelin-receptor agonist. Evidence grade A. US status: Not verified.
- [GHRP-6](https://chia.health/blog/ghrp-6): Growth-hormone-releasing peptide with marked appetite stimulation. Evidence grade A. US status: Not verified.
- [hCG](https://chia.health/blog/hcg): Approved gonadotropin used in fertility and hypogonadism protocols. Evidence grade A. US status: Not verified.
- [IGF-1 LR3](https://chia.health/blog/igf-1-lr3): Modified insulin-like growth factor 1 analogue sold as a research reagent. Evidence grade E. US status: Not verified.
- [Melanotan II](https://chia.health/blog/melanotan-2): Unapproved melanocortin agonist sold online for tanning; associated with safety reports. Evidence grade A. US status: Not verified.
- [Selank](https://chia.health/blog/selank): Synthetic tuftsin analogue used in Russia for anxiety. Evidence grade A. US status: Not verified.
- [SS-31](https://chia.health/blog/ss-31): Mitochondria-targeting tetrapeptide investigated in mitochondrial myopathy. Evidence grade A. US status: Not verified.
- [Thymosin Beta-4](https://chia.health/blog/thymosin-beta-4): Actin-sequestering peptide studied in wound healing and cardiac repair. Evidence grade A. US status: Not verified.
- [Urolithin A](https://chia.health/blog/urolithin-a): Gut-microbial ellagitannin metabolite studied for mitophagy and muscle endurance. Evidence grade A. US status: Not verified.
- [ARA-290](https://chia.health/blog/ara-290): Erythropoietin-derived peptide studied in small-fibre neuropathy. Evidence grade A. US status: Not verified.
- [Cerebrolysin](https://chia.health/blog/cerebrolysin): Porcine brain-derived peptide preparation used outside the US in stroke and dementia. Evidence grade A. US status: Not verified.
- [Dihexa](https://chia.health/blog/dihexa): Angiotensin IV analogue studied preclinically as an HGF/c-Met potentiator. Evidence grade C. US status: Not verified.
- [Hexarelin](https://chia.health/blog/hexarelin): Synthetic hexapeptide growth-hormone secretagogue. Evidence grade A. US status: Not verified.
- [Humanin](https://chia.health/blog/humanin): Mitochondrial-derived peptide studied in cytoprotection and ageing. Evidence grade A. US status: Not verified.
- [Larazotide](https://chia.health/blog/larazotide): Tight-junction regulator peptide investigated in coeliac disease. Evidence grade A. US status: Not verified.
- [LL-37](https://chia.health/blog/ll-37): Human cathelicidin antimicrobial peptide studied in innate immunity. Evidence grade A. US status: Not verified.
- [Mazdutide](https://chia.health/blog/mazdutide): Investigational GLP-1/glucagon receptor agonist. Evidence grade A. US status: Not verified.
- [P21](https://chia.health/blog/p21): Peptide studied preclinically for neurogenesis. Evidence grade A. US status: Not verified.
- [Pentosan Polysulfate](https://chia.health/blog/pentosan-polysulfate): Semi-synthetic polysaccharide approved for interstitial cystitis. Evidence grade A. US status: Not verified.
- [Spermidine](https://chia.health/blog/spermidine): Polyamine studied as an autophagy inducer in ageing research. Evidence grade A. US status: Not verified.
- [Survodutide](https://chia.health/blog/survodutide): Investigational dual glucagon/GLP-1 receptor agonist. Evidence grade A. US status: Not verified.

## Products
- [NAD+](https://chia.health/product/nad): Cellular energy, focus and repair — from $119.00/mo
- [Semaglutide](https://chia.health/product/semaglutide): GLP-1 weight loss and appetite control — from $249.00/mo
- [Tirzepatide](https://chia.health/product/tirzepatide): Dual GIP/GLP-1 weight loss — from $249.00/mo
- [Sermorelin](https://chia.health/product/sermorelin): Restores natural growth-hormone rhythm — from $179.00/mo
- [Glutathione](https://chia.health/product/glutathione): The body's master antioxidant — from $179.00/mo
- [GHK-Cu Cream](https://chia.health/product/ghk-cu): Skin renewal, collagen and firmness — from $159.00/mo
- [PT-141](https://chia.health/product/pt-141): Reignite desire and arousal — from $159.00/mo
- [Low-Dose Naltrexone](https://chia.health/product/ldn): Immune balance and healthy aging — from $59.00/mo
- [Estradiol](https://chia.health/product/estradiol): Bioidentical estrogen for menopause relief — from $109.00/mo
- [Progesterone](https://chia.health/product/progesterone): Bioidentical progesterone — balance and protection — from $79.00/mo

## Protocols (physician-curated combinations)
- [Weight + Energy Protocol](https://chia.health/protocol/weight-energy): Lose weight on GLP-1 without the energy crash — from $309.00/mo
- [GLP-1 + Sermorelin Protocol](https://chia.health/protocol/glp1-sermorelin): Lose the fat without losing the muscle — from $329.00/mo
- [Menopause Relief Protocol](https://chia.health/protocol/hrt-women): Relieve menopause symptoms with hormones tailored to you — from $119.00/mo
- [Foundation Longevity Protocol](https://chia.health/protocol/foundation-longevity): The starting point for slowing how you age — from $399.00/mo
- [Glow Protocol](https://chia.health/protocol/glow): Firmer, healthier, younger-looking skin — from $349.00/mo
- [Spark Protocol](https://chia.health/protocol/spark): Reignite desire — for women and men — from $159.00/mo

## Categories (by health goal)
- [Weight Loss Treatments](https://chia.health/category/weight-loss): Lose up to 20% of your body weight with physician-prescribed GLP-1 therapy — paired with support to protect your energy and lean muscle along the way.
- [Longevity Treatments](https://chia.health/category/longevity): Not sure which longevity treatment is right for you? Answer a few questions — your physician will recommend the right protocol based on your goals and health profile.
- [Strength Treatments](https://chia.health/category/strength): Build and preserve lean muscle by restoring your natural growth-hormone pulse and the cellular energy that powers training and recovery.
- [Sexual Wellness Treatments](https://chia.health/category/sexual): Reignite desire with PT-141 — a physician-prescribed therapy that works on the brain pathways behind wanting, for women and men.
- [Mind Treatments](https://chia.health/category/mind): Sharpen focus, memory and mental stamina by protecting your neurons and restoring the cellular energy your brain runs on.
- [Skin & Aesthetics Treatments](https://chia.health/category/skin): Firmer, healthier, younger-looking skin — a copper-peptide cream that rebuilds collagen, backed by physician-supervised care.
- [Immune & Inflammation Treatments](https://chia.health/category/immune-inflammation): Calm the low-grade inflammation and immune strain that wear the body down — anchored by low-dose naltrexone, with glutathione for antioxidant support, under physician guidance.

## Key pages
- [Health assessment / get started](https://chia.health/onboarding/questionnaire)
- [Blog — evidence-based treatment guides](https://chia.health/blog)
- [Legal & privacy](https://chia.health/legal)